Mark J Alles Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Mark J Alles is Director of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 3,666 shares of SYRS, which is worth approximately $18,439. The most recent transaction as insider was on Sep 16, 2023, when has been sold 2,666 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.67K
0% 3M change
n/a 12M change
Total Value Held $18,439

Mark J Alles Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2023
BUY
Exercise of conversion of derivative security
-
2,666 Added 42.1%
3,666 Common Stock

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
MJA

Mark J Alles

Director
San Diego, CA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS